Home › Ventricular Tachycardia › Tennessee
Ventricular Tachycardia clinical trials in Tennessee
6 studies for Ventricular Tachycardia are looking for participants at sites in Tennessee.
Cities in Tennessee
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 85 · All sexes · Updated Sep 3, 2026 · NCT06703489Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07650032The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
- Le Bonheur Children's Hospital, Memphis
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Jul 21, 2026 · NCT05763953Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06575881Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT05765175Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2025 · NCT05337241From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.